Literature DB >> 239967

Sickling times of individual erythrocytes at zero Po2.

H S Zarkowsky, R M Hochmuth.   

Abstract

A rapid-reaction parallel-plate flow channel was used to study the kinetics of erythrocyte sickling upon sudden deoxygenation with sodium dithionite. The erythrocytes were recorded on 16-mm film or video tape and visually tracked in time. Sickling was identified by morphologic criteria. At the flow rate used in these studies, the rate of sickling was a reaction-limited process. There was no loss of cellular deformability or membrane flicker before the onset of sickling. Typical sickling times for sickle (SS) cells and trait (AS) cells at room temperature in isotonic buffer were 2.0 and 70 s, respectively. Increasing the buffer osmolality resulted in shorter sickling times and under hypotonic conditions the time required for sickling was prolonged. Between pH 6.4 and 7.0 there was little change in the time required for 50% of the originally discoidal cells to sickle (t50); whereas a marked increase in t50 occurred between pH 7.4 and 7.6. Whole populations of AS and SS erythrocytes were separated into three fractions after centrifugation. The t50 of the fractions progressively decreased from top to bottom, which paralleled an increase in mean corpuscular hemoglobin concentration (MCHC). The t50 decreased as the temperature was increased from 13 degrees to 34 degrees C. This temperature effect was more pronounced for cells that had osmotically induced reductions in MCHC. A two-step process for erythrocyte sickling is proposed: an initial lag phase, during which there is little or no change in internal viscosity, followed by a rapid phase of cellular deformation. The lag phase is altered by changes in MCHC, pH, and temperature.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 239967      PMCID: PMC301958          DOI: 10.1172/JCI108149

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Observations on the sickling phenomenon and on the distribution of different haemoglobin types in erythrocyte populations.

Authors:  A C ALLISON
Journal:  Clin Sci       Date:  1956-11       Impact factor: 6.124

2.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

3.  A temperature-dependent latent-period in the aggregation of sickle-cell deoxyhemoglobin.

Authors:  R Malfa; J Steinhardt
Journal:  Biochem Biophys Res Commun       Date:  1974-08-05       Impact factor: 3.575

4.  The rates of polymerization and depolymerization of sickle cell hemoglobin.

Authors:  K Moffat; Q H Gibson
Journal:  Biochem Biophys Res Commun       Date:  1974-11-06       Impact factor: 3.575

5.  Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers.

Authors:  J T Finch; M F Perutz; J F Bertles; J Döbler
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

6.  Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease.

Authors:  J Hofrichter; P D Ross; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Measurement of the elastic modulus for red cell membrane using a fluid mechanical technique.

Authors:  R M Hochmuth; N Mohandas; P L Blackshear
Journal:  Biophys J       Date:  1973-08       Impact factor: 4.033

8.  Erythrocyte O2 affinity: influence of cell density and in vitro changes in hemoglobin concentration.

Authors:  J R Murphy; M Wengerd; R W Kellermeyer
Journal:  J Lab Clin Med       Date:  1974-08

9.  The rate of sickling of cells containing sickle-cell haemoglobin.

Authors:  M W Rampling; J A Sirs
Journal:  Clin Sci Mol Med       Date:  1973-11

10.  RATE OF SICKLING OF RED CELLS DURING DEOXYGENATION OF BLOOD FROM PERSONS WITH VARIOUS SICKLING DISORDERS.

Authors:  S CHARACHE; C L CONLEY
Journal:  Blood       Date:  1964-07       Impact factor: 22.113

View more
  10 in total

1.  Nucleation of sickle hemoglobin mixed with hemoglobin A: experimental and theoretical studies of hybrid-forming mixtures.

Authors:  Maria Rotter; Donna Yosmanovich; Robin W Briehl; Suzanna Kwong; Frank A Ferrone
Journal:  Biophys J       Date:  2011-12-07       Impact factor: 4.033

Review 2.  Pharmacological modification of hemoglobin F expression in sickle cell anemia: an update on hydroxyurea studies.

Authors:  S Charache
Journal:  Experientia       Date:  1993-02-15

3.  Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease.

Authors:  Quan Li; Eric R Henry; James Hofrichter; Jeffrey F Smith; Troy Cellmer; Emily B Dunkelberger; Belhu B Metaferia; Stacy Jones-Straehle; Sarah Boutom; Garrott W Christoph; Terri H Wakefield; Mary E Link; Dwayne Staton; Erica R Vass; Jeffery L Miller; Matthew M Hsieh; John F Tisdale; William A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

4.  Hypoxia-enhanced adhesion of red blood cells in microscale flow.

Authors:  Myeongseop Kim; Yunus Alapan; Anima Adhikari; Jane A Little; Umut A Gurkan
Journal:  Microcirculation       Date:  2017-07       Impact factor: 2.628

5.  Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.

Authors:  L R Berkowitz; E P Orringer
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

6.  Molecular and cellular pathogenesis of hemoglobin SC disease.

Authors:  H F Bunn; C T Noguchi; J Hofrichter; G P Schechter; A N Schechter; W A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Determination of deoxyhemoglobin S polymer in sickle erythrocytes upon deoxygenation.

Authors:  C T Noguchi; D A Torchia; A N Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Inhibition of erythrocyte sickling by cystamine, a thiol reagent.

Authors:  W Hassan; Y Beuzard; J Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

9.  Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease.

Authors:  Belhu Metaferia; Troy Cellmer; Emily B Dunkelberger; Quan Li; Eric R Henry; James Hofrichter; Dwayne Staton; Matthew M Hsieh; Anna K Conrey; John F Tisdale; Arnab K Chatterjee; Swee Lay Thein; William A Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

10.  Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.

Authors:  Marcus A Carden; Meredith E Fay; Xinran Lu; Robert G Mannino; Yumiko Sakurai; Jordan C Ciciliano; Caroline E Hansen; Satheesh Chonat; Clinton H Joiner; David K Wood; Wilbur A Lam
Journal:  Blood       Date:  2017-10-04       Impact factor: 25.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.